Stephen P. Ethier

Medical University of South Carolina — United States

Medicine · Health Sciences

62h-index14.2kcitations305works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(77), Cancer Cells and Metastasis(47), Epigenetics and DNA Methylation(39), Monoclonal and Polyclonal Antibodies Research(38), Cancer-related Molecular Pathways(28)

Publications304 total

A phase 1b study of Plk1 inhibitor onvansertib in combination with paclitaxel in metastatic triple-negative breast cancer (mTNBC) patients.
Journal of Clinical Oncology·2025· 1 cited
A Bayesian framework for pathway‐guided identification of cancer subgroups by integrating multiple types of genomic data
Statistics in Medicine·2023· 4 citedOpen Access
Data from SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
2023Open Access
Supplementary Tables 1-7 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Supplementary Figures 1-4 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Supplementary Tables 1-7 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Supplementary Figure 1 from SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
2023Open Access
Data from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Supplementary Figure 2 from SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
2023Open Access
Supplementary Figure 2 from SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
2023Open Access
Data from SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
2023Open Access
Supplementary Figure 1 from SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
2023Open Access
Supplementary Figures 1-4 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Data from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2023Open Access
Data from MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer
2023Open Access
Supplementary Figures and Legends from MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
2023Open Access
Data from MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure Legends from MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer
2023Open Access
Data from MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
2023Open Access
Supplementary Methods from MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Joe W. Gray(3), Richard L. Wahl(3), Aliccia Bollig‐Fischer(3), Judith Abrams(3), Guojun Wu(3), Ramsi Haddad(3), Sonja M. Markwart(3), Donna L. Livant(3), Richard M. Neve(2), Donna G. Albertson(2), Frank McCormick(2), Marc E. Lippman(2), Lao H. Saal(2), Sofia K. Gruvberger-Saal(2), Kristina Lövgren(2), Karolina Holm(2), Åke Borg(2), Antoinette Hollestelle(2), Jord H.A. Nagel(2), Fons Elstrodt(2)